Drug innovation and product pipelines in the cardiometabolic field lag due to the inherent time and cost of evidence generation required for regulatory evaluation and approval.
Several factors can impact delivery success, drive up costs, and potentially delay time to market, including slow enrollment, longer trial durations, intensive testing associated with trials, and signal detection delays associated with endpoint capture.
In this free webinar, industry experts from Syneos and Medable will share their perspectives on how to address these drug development challenges in cardiometabolic clinical research and provide input on the impact of new regulatory guidance such as the DEPICT Act . This engaging panel will discuss leveraging technology and home health solutions to enhance existing points of care between patients and their clinical care teams to improve the patient experience, drive more scientific data generation and enable timely endpoint capture.
The main learning objectives of this webinar include:
- Best practices for addressing key delivery pain points in cardiometabolic trials (including wearables/sensors/connected devices) using digital and home health solutions
- How to Leverage Technology to Achieve Better Patient Representation in Trials to Meet New DEI Regulatory Guidance
- How to use best-in-class digital solutions to accelerate time-to-target while improving patient experience
who should attend
- Clinical Operations/Development Professionals
- Cardiometabolic TA Key Professionals
- R&D IT/Technical Professionals
- Chief Diversity Officer (DEI related role)
- Chief Medical Officer/Chief Scientific Officer
- Clinical Trial Strategy Team Professionals
Can’t attend?We recommend that you still register, you will receive an email
and how to access the record of events.
